INDUSTRY SPOTLIGHT

Predictive Health & Life Sciences

Where drug discovery is accelerated, clinical trials are optimized, and patient care is truly personalized.

THE INDUSTRY IS CHANGING

Data Fragmentation Defines the Industry.

The potential to transform health outcomes with AI is immense, but it remains locked in silos. Data from clinical trials, electronic health records (EHRs), genomics, and real-world evidence is fragmented and impossible to connect. We solve this foundational challenge by unifying complex data at scale while adhering to the strictest privacy and compliance standards.

Health industry

CORE CHALLENGES

Systemic Problems in Health & Life Sciences

We harness the power of AI to solve challenges in every facet of the sector, from the lab to the clinic.

Slow Drug Discovery Cycles

Siloed clinical and genomic data makes it incredibly slow and expensive to identify novel drug targets and predict treatment efficacy.

Inefficient Clinical Trials

Patient recruitment is slow, data from trial sites is fragmented, and predicting delays is nearly impossible, leading to high costs.

One-Size-Fits-All Patient Care

Generic treatment plans based on broad population data fail to account for individual patient differences, leading to suboptimal outcomes.

Regulatory & Compliance Burden

Navigating complex compliance landscapes (e.g., HIPAA, GxP) with siloed data is a major operational risk and barrier to innovation.

THE AKIN APPROACH

A Single, Compliant Core for Research and Care.

We build a unified, intelligent system that serves both research and clinical operations. By creating a secure, compliant, and unified ontology, we provide the foundational 'digital twin' of your data ecosystem, enabling breakthroughs in both drug discovery and patient care.

SYSTEMS ARCHITECTURE

The Health Ontology: Your Digital Twin

This is our core differentiator. We build a deep, semantic model of your entire data ecosystem, creating the 'single source of truth' required for trustworthy AI.

Patient 360 & Genomics Ontology

A unified, longitudinal model of patient data, connecting EHRs, genomics, and real-world evidence for a holistic view.

Research & Discovery Ontology

A knowledge graph connecting compounds, diseases, genes, and clinical trial data to accelerate the identification of novel therapeutic targets.

Clinical Operations Ontology

A digital twin of your clinical trial pipeline, modeling sites, patient cohorts, and protocols to optimize for speed and efficiency.

Real-World Evidence (RWE) Ontology

An integrated model of data from wearables, claims, and patient registries to understand treatment effects outside of clinical trials.

CAPABILITIES

Platform Capabilities for Health & Life Sciences

Discover how the Akin Platform accelerates innovation and improves outcomes across the healthcare value chain.

AI-Powered Target Identification

AI agents that analyze the Research Ontology to identify novel drug targets and predict their likelihood of success.

Value: Dramatically accelerates the pre-clinical phase of drug discovery and increases the probability of success.

Intelligent Clinical Trial Design

Uses AI to optimize trial protocols and patient cohort selection, identifying the fastest path to regulatory submission.

Value: Reduces clinical trial timelines and costs, bringing life-saving therapies to market faster.

Personalized Medicine & Care Pathways

Leverages the Patient 360 Ontology to develop predictive models for disease progression and treatment response.

Value: Empowers clinicians to deliver tailored treatment plans that improve patient outcomes.

Automated Regulatory Compliance

Provides a secure, auditable data foundation (designed to support HIPAA and GxP requirements) for all research and clinical operations.

Value: De-risks innovation by ensuring compliance is built-in, not bolted on, and simplifies regulatory submissions.

Real-World Evidence Analysis

Analyzes diverse RWE sources to understand long-term treatment effectiveness and identify new indications.

Value: Maximizes the value of therapeutic assets post-approval and informs future R&D strategy.

Genomic Data Harmonization

Integrates and harmonizes vast genomic and multi-omic datasets to power advanced bioinformatics and discovery.

Value: Unlocks the full potential of your genomic data for building next-generation therapeutics.

ARCHITECTURE

Health & Life Sciences Architecture Diagram

Health architecture diagram

In practice

How these architectures create value

Illustrative scenarios show the outcomes these architectures are designed to deliver. They are targets, not verified client results. Verified results state the baseline, measurement period, method and Akin’s role.

Illustrative scenario

Typical setting: Top 10 Pharma Company

Fragmented R&D Data → Unified Discovery Platform

Built a Research Ontology that unified data from 50+ internal and external databases.

Target outcome

2x increase in viable drug target identification

Illustrative scenario

Typical setting: Global CRO

Manual Patient Recruitment → AI-Powered Cohort Selection

Deployed an AI model to identify optimal patient cohorts from EHR data for a complex oncology trial.

Target outcome

30% faster clinical trial recruitment

INTEGRATION

Architected for Your Stack

Our platform is designed to unify your existing EHR, LIMS, and clinical trial management systems, not replace them.

EHR / LIMS

Genomic Data

Akin Unified Ontology

Cognitive Agents

Clinical Ops

GET STARTED

Architect Intelligence for Health & Life Sciences.

We work with leaders who want to accelerate discovery and personalize patient care. Let's build your blueprint.